BB BIOTECH AG

BION
Delayed Quote. Delayed  - 12/03 11:30:41 am
75.2CHF -2.15%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 4 1084 166
Entreprise Value (EV)1 2094 190
P/E ratio 5,94x7,39x
Yield 4,86%5,35%
Capitalization / Revenue 5,54x-23,8x
EV / Revenue 0,28x-23,9x
EV / EBITDA 0,30x7,44x
Price to Book 1,05x0,94x
Nbr of stocks (in thousands) 55 40055 400
Reference price (CHF) 74,275,2
Announcement Date 02/19/2021-
Previous period Next period
1 CHF in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 742-175
EBITDA1 694563
Operating profit (EBIT)1 692317
Operating Margin 93,3%-181%
Pre-Tax Profit (EBT)1 691217
Net income1 691439
Net margin 93,2%-251%
EPS2 12,510,2
Dividend per Share2 3,604,02
Announcement Date 02/19/2021-
Previous period Next period
1 CHF in Million
2 CHF
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 -23,5
Net Cash position1 3 898-
Leverage (Debt / EBITDA) -5,62x0,04x
Free Cash Flow1 26292,7
ROE (Net Profit / Equities) 19,0%8,00%
Shareholders' equity1 3 6395 493
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share2 70,380,4
Cash Flow per Share --
Capex --
Capex / Sales --
Announcement Date 02/19/2021-
Previous period Next period
1 CHF in Million
2 CHF
Financial Ratios
Size 2021e 2022e
Capitalization 4 166 M CHF -
Entreprise Value (EV) 4 190 M CHF 4 189 M CHF
Valuation 2021e 2022e
P/E ratio (Price / EPS) 7,39x 14,8x
Capitalization / Revenue -23,8x -
EV / Revenue -23,9x -
EV / EBITDA 7,44x 14,9x
Yield (DPS / Price) 5,35% 5,68%
Price to book (Price / BVPS) 0,94x 0,88x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) -181% -
Operating Leverage (Delta EBIT / Delta Sales) -0,44x -
Net Margin (Net Profit / Revenue) -251% -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 8,00% 7,50%
Rate of Dividend 39,5% 84,1%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   -0 -
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,04x 0,08x
Price Earning Ratio
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS & Dividend